Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT), takes office as president of the SNMMI Technologist Section
Business Announcement
Updates every hour. Last Updated: 31-May-2026 16:15 ET (31-May-2026 20:15 GMT/UTC)
A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) in Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors. The results show overall good tolerability and clear signs of effectiveness of this novel immunotherapy. They are published in the renowned scientific journal Nature Medicine.